ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,492, issued on May 20, was assigned to Purdue Pharma LP (Stamford, Conn.).
"Compounds for treating TNBC" was invented by Thomas Jorg Mehrling (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided tinostamustine or a pharmaceutically acceptable salt thereof for use in the treatment of triple negative breast cancer (TNBC) to a patient in need thereof."
The patent was filed on Sept. 12, 2023, under Application No. 18/244,913.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=5...